[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aptargroup (ATR)

Aptargroup (ATR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Is West Pharmaceutical Stock Outperforming the S&P 500?

West Pharmaceutical continues to outpace broader market gains on strong earnings momentum and supportive analyst sentiment.

$SPX : 7,431.46 (+0.50%)
WST : 328.82 (-0.46%)
ATR : 117.72 (+0.98%)
Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year

Recognized for Continued Supply Chain Collaboration

ATR : 117.72 (+0.98%)
Aptar to Participate in Upcoming Investor Conferences

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it will present at two upcoming investor conferences:...

ATR : 117.72 (+0.98%)
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot

AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance and early...

ATR : 117.72 (+0.98%)
AptarGroup: Q1 Earnings Snapshot

AptarGroup: Q1 Earnings Snapshot

ATR : 117.72 (+0.98%)
Aptar Reports First Quarter 2026 Results

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following first quarter results for the period ended...

ATR : 117.72 (+0.98%)
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

Digital solution will be designed to help guide users through injection process

ATR : 117.72 (+0.98%)
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

Use of Aptar Pharma’s UDS Powder system supports the development of a next‑generation, virus‑agnostic nasal spray being evaluated for its potential to help protect against symptomatic viral respiratory...

ATR : 117.72 (+0.98%)
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more...

ATR : 117.72 (+0.98%)

Barchart Exclusives

Qualcomm Is Striving for a Bigger Piece of AI Infrastructure. Here’s What That Means for QCOM Stock.
J.P. Morgan released a bullish note on Qualcomm despite its core business facing headwinds in the short term. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.